Development Level

Tbio 5 | 10,625

IMPC Term

decreased mean corpuscular vol... 1 | 50
increased hemoglobin content 1 | 45

Disease

ovarian cancer 5 | 8,484
atypical teratoid / rhabdoid tumor 4 | 4,369
Cancer 3 | 2,346
medulloblastoma, large-cell 3 | 6,234
non-small cell lung cancer 3 | 2,798
osteosarcoma 3 | 7,933
psoriasis 3 | 6,685
subependymal giant cell astrocytoma 3 | 2,287
IGA Glomerulonephritis 2 | 454
Neurodegenerative disease 2 | 383
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
group 3 medulloblastoma 2 | 2,254
interstitial cystitis 2 | 2,299
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
non primary Sjogren syndrome sicca 2 | 840
pancreatic cancer 2 | 2,300
Arthritis 1 | 248
Attention deficit hyperactivity disorder 1 | 156
Autosomal dominant nonsyndromic deafness 1 | 5
Brain disease 1 | 83
Carcinoma 1 | 2,147
Chagas disease 1 | 34
Chromosome 1p36 deletion syndrome 1 | 24
Cryptosporidiosis 1 | 12
Eye disease 1 | 55
Gastrointestinal system disease 1 | 50
Gaucher disease type 1 1 | 171
Gout 1 | 93
Heart disease 1 | 279
Hypersensitivity reaction type II disease 1 | 235
Invasive Ductal Breast Carcinoma 1 | 9
Leishmaniasis 1 | 49
Lupus erythematosus 1 | 80
Machado-Joseph disease 1 | 18
Malaria 1 | 140
Mammary Neoplasms 1 | 410
Meniere's disease 1 | 24
Multiple myeloma 1 | 1,327
Muscular Dystrophy, Facioscapulohumeral 1 | 12
Pick disease 1 | 1,893
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16 1 | 1
Spindle cell hemangioma 1 | 16
Toxic encephalopathy 1 | 131
Toxoplasmosis 1 | 16
Tularemia 1 | 22
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
adrenocortical carcinoma 1 | 1,427
aldosterone-producing adenoma 1 | 664
astrocytic glioma 1 | 2,241
chronic lymphosyte leukemia 1 | 232
cutaneous lupus erythematosus 1 | 1,056
ductal carcinoma in situ 1 | 1,745
ependymoma 1 | 2,514
glioblastoma 1 | 5,572
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
malignant mesothelioma 1 | 3,162
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
oligodendroglioma 1 | 2,849
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pediatric high grade glioma 1 | 2,712
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primary Sjogren syndrome 1 | 789
primitive neuroectodermal tumor 1 | 3,031
sarcoidosis 1 | 358
spina bifida 1 | 1,064
tuberculosis 1 | 1,557
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01GM075156-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
BAG family molecular chaperone regulator 1 BAG1 Tbio Non-IDG -2.48320 329.1 359
E3 ubiquitin-protein ligase CHIP STUB1 Tbio Enzyme -2.89279 813.5 313
Ubiquitin conjugation factor E4 B UBE4B Tbio Non-IDG -1.81602 67.4 132
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Heat shock 70 kDa protein 4 HSPA4 Tbio Non-IDG -3.91589 8441.3 353